Navigation Links
Separating science fiction from reality in the human cloning debate

Madison, Wis. After Gov. Jim Doyle vetoed a bill that would have banned cloning of human embryonic stem cells for research purposes, the legislative director of Wisconsins Right to Life movement made a remark that seemed straight out of a science fiction movie.

We're not talking about stem cells anymore; we're talking about growing these embryos . . ......

Full article >>> egulated research into disease using human embryonic embryos is an entirely different matter.

First or all, scientists have been cloning human cells or their components for years. The process known as DNA cloning, molecular cloning or gene cloning has been used widely since the 1970s. It involves the transfer of a DNA fragment of interest from one organism to a self-replicating genetic e......

Full article >>> the process less than 10 years ago.

If that kind of work isnt done here under existing ethical guidelines that are a national model it will be done someplace else. Certainly, its being done in South Korea and the United Kingdom, where therapeutic cloning was protected four years ago.

The debate over stem cell research is complicated enough without sci-fi claims that mislead pol......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 11/07/05


Related biology technology :

1. Separating hope from hype in stem-cell research
2. Food science: increasing crop yields
3. NanoRite Innovation Center opens with small science, big promise
4. Midwest life science stocks kept sizzling in Q2
5. Perscitus Biosciences secures $250K Commerce loan
6. Wisconsin biosciences rise to the challenge
7. Midwest life science stocks sizzle in a tepid first quarter
8. Quintessence Biosciences advances cancer drug
9. A Midwest life-science odyssey comes full circle
10. Bioscience clusters: Too many or room for more?
11. Quintessence Biosciences names new president
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)...  Protagonist Therapeutics, Inc. (NASDAQ: PTGX ... global Phase 2b induction study in ulcerative colitis ... integrin. The aim of this randomized, double-blind, placebo-controlled, ... and efficacy of PTG-100 in approximately 240 adult ... disease. "We are very pleased ...
(Date:1/16/2017)... NY (PRWEB) , ... January 16, 2017 , ... ... New Jersey laws precedential publication its decision on the appeal filed by India-based ... lawsuit of breach of contract against DPCL and one of its Dishman Group’s ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Tibbetts Award from the U.S. Small Business Administration. The Tibbetts Award ... economic or social impact […] and are considered the best of the best ...
(Date:1/14/2017)... ... 14, 2017 , ... Seattle-based Phase Genomics has announced the ... researchers around the globe. Long considered a “holy grail” in biological research, ... of scientific questions. The announcement was made today at the Plant & ...
Breaking Biology Technology:
(Date:1/6/2017)... NEWARK, Calif. , Jan. 5, 2017  Delta ... introduced its iris scanning technology for automotive at CES® ... GNTX ) to demonstrate the use of ... to identify and authenticate the driver in a car, ... automobiles during the driving experience. Delta ID ...
(Date:12/22/2016)... VIEW, Calif. , Dec. 20, 2016  As part ... levels, 23andMe, the leading personal genetics company, recently released its ... Me . The book focuses on the topics of ... Next Generation Science Standards (NGSS) taught in elementary school classrooms ... second in a series by illustrator Ariana Killoran , ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
Breaking Biology News(10 mins):